Characterizing the role of PCBP1 in the activation of the cGAS-STING/type I Interferon axis to promote anti-tumor immunity

被引：0
|
作者：
Frereux, Cecile
Chakraborty, Paramita
Dalton, Annamarie C.
Howley, Breege V.
Granger, Bryan
Karam, Joseph A.
Vaena, Silvia G.
Romeo, Martin J.
Howe, Philip H.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7460
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Bortezomib Induces Anti-Multiple Myeloma Immune Response Mediated By Cgas/Sting Pathway Activation, Type I Interferon Secretion, and Immunogenic Cell Death: Clinical Application
    Gulla, Annamaria
    Morelli, Eugenio
    Samur, Mehmet Kemal
    Botta, Cirino
    Hideshima, Teru
    Bianchi, Giada
    Fulciniti, Mariateresa
    Malvestiti, Stefano
    Prabhala, Rao
    Talluri, Srikanth
    Tai, Yu-Tzu
    Wen, Kenneth
    Richardson, Paul G.
    Carrasco, Ruben D.
    Chauhan, Dharminder
    Munshi, Nikhil C.
    Anderson, Kenneth
    BLOOD, 2020, 136
  • [42] Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
    Duong, Ellen
    Fessenden, Tim B.
    Lutz, Emi
    Dinter, Teresa
    Yim, Leon
    Blatt, Sarah
    Bhutkar, Arjun
    Wittrup, Karl Dane
    Spranger, Stefani
    IMMUNITY, 2022, 55 (02) : 308 - +
  • [43] TYPE-I-INTERFERON ACTIVATES CROSS-DRESSED CD11B+CONVENTIONAL DENDRITIC CELLS TO ENHANCE ANTI-TUMOR IMMUNITY
    Duong, Ellen
    Fessenden, Timothy
    Lutz, Emi
    Dinter, Teresa
    Yim, Leon
    Blatt, Sarah
    Bhutkar, Arjun
    Wittrup, K.
    Spranger, Stefani
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A711 - A711
  • [44] Role of the 1,3-β-D-glucan receptor Dectin-1 in fungal infection and activation of innate and anti-tumor immunity
    Yoshiyuki, Adachi
    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 2007, 19 (108-09) : 195 - 207
  • [45] Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC)
    Yan, Yihe
    Zheng, Leting
    Du, Qiang
    Yazdani, Hamza
    Dong, Kun
    Guo, Yarong
    Geller, David A.
    CANCER LETTERS, 2021, 506 : 95 - 106
  • [46] Inhibition of Checkpoint Kinase 1 (CHK1) Upregulates Interferon Regulatory Factor 1 (IRF1) to Promote Apoptosis and Activate Anti-Tumor Immunity via MICA in Hepatocellular Carcinoma (HCC)
    Li, Xicai
    Huang, Jingquan
    Wu, Qiulin
    Du, Qiang
    Wang, Yingyu
    Huang, Yubin
    Cai, Xiaoyong
    Geller, David A.
    Yan, Yihe
    CANCERS, 2023, 15 (03)
  • [47] m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon
    Sun, Yiqi
    Liu, Yunfei
    Jiang, Lu
    Zhong, Chao
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [48] BOTENSILIMAB, AN FC-ENHANCED CTLA-4 ANTIBODY, ENHANCES INNATE AND ADAPTIVE IMMUNE ACTIVATION TO PROMOTE SUPERIOR ANTI-TUMOR IMMUNITY IN COLD AND I-O REFRACTORY TUMORS
    Delepine, Chloe
    Levey, Daniel
    Krishnan, Shanmugarajan
    Kim, Kwang-Soo
    Sonabend, Adam
    Wilkens, Margaret
    Tanne, Antoine
    Garcia-Brocano, Pilar
    Galand, Claire
    Han, Haiyong
    MacDermaid, Christopher
    Chow, Jacky
    Vincent, Sylvia
    Karkwal, Shalu
    Sun, Yan
    Smith, Racehl
    Michelet, Xavier
    Teong, Kah
    Rosenthal, Katherine
    Savitsky, David
    Joyce, Cailin
    O'Day, Steven
    Grossman, Joseph
    Patel, Jaymin
    Chand, Dhan
    Levey, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A490 - A490
  • [49] Blocking MARCO plus tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway
    Ding, Limin
    Qian, Junjie
    Yu, Xizhi
    Wu, Qinchuan
    Mao, Jing
    Liu, Xi
    Wang, Yubo
    Guo, Danjing
    Su, Rong
    Xie, Haiyang
    Yin, Shengyong
    Zhou, Lin
    Zheng, Shusen
    CANCER LETTERS, 2024, 582
  • [50] The VISTA blocking antibody HMBD-002 promotes type-I interferon signaling and drives anti-tumor responses through macrophage reprograming and cytotoxic CD8+T cell activation
    Dharmadhikari, Bhushan
    Zharkova, Olga
    Thakkar, Dipti
    Tirado-Magallanes, Roberto
    Paszkiewicz, Konrad
    Ingram, Piers J.
    Boyd-Kirkup, Jerome D.
    CANCER RESEARCH, 2024, 84 (06)
12345